Find investors
← Back to all investors
David Browne
ResearchedAngel Investors

David Browne

Principal

Angel InvestorsSeed Round
Pitch David

Get their honest, personalized take on your startup.

Sign in to pitch David

At a glance

Full Name
David Browne
Title
Chief Financial Officer
Firm
Tarsadia Investments
Firm Type
Multi-strategy private investment firm / multifamily office (permanent capital base)
Investment Stage
Venture, growth equity, and later-stage private investments (firm invests across stages, from Series A through growth rounds)
Sector Focus
Venture & growth equity, life sciences, real estate, and public/private equities — historically active in healthtech, fintech, proptech, mobility, and biopharma
Geographic Focus
Primarily U.S., with meaningful international exposure (notably Latin American fintech — Brazil and Mexico)
Location
Newport Beach, California, USA

Background

David Browne is the Chief Financial Officer of Tarsadia Investments, the private investment management vehicle of Tarsadia — a multibillion-dollar family office and multi-strategy firm founded in 1976 and headquartered in Newport Beach, California, with an additional office in New York City. In his role he oversees strategic financial management, planning and reporting, accounting, asset management, and strategy across the firm's investment platforms (venture & growth equity, life sciences, real estate, and public/private markets). Tarsadia reports $2B+ in AUM, roughly 28 portfolio companies, 30+ years of operating history, and about 20 investment professionals.

Before joining Tarsadia, Browne served as Chief Financial Officer of Sabal Capital Holdings (a Stone Point Capital portfolio company) and as CFO of MMP Holdings (a Levine Leichtman Capital Partners portfolio company, associated with Mountain Mike's Pizza). Earlier in his career he was a Partner with middle-market private equity firm Marwit Investment Management (Marwit Capital), a Vice President at The Compass Group International, and an Analyst at Aurora Capital Group. He began his career in the High Yield Finance group at Merrill Lynch & Co. in New York.

Browne holds an M.B.A. from the Kellogg School of Management at Northwestern University and a B.S. in Economics from The Wharton School of the University of Pennsylvania.

Investment Thesis & Focus

  • As CFO, Browne is a firm executive and financial steward rather than a deal-leading investor with a personal angel thesis; investment decisions are made at the firm level across Tarsadia's strategies.
  • Tarsadia positions itself as making "long-term, high-conviction investments" in "durable, transformative companies operating in large markets," backed by a permanent capital base and a flexible, generalist mandate that lets it invest across stages and sectors.
  • Core strategies: venture & growth equity, life sciences / biopharma, real estate (hotels, office, net-lease), and public/private equities.
  • Historically most active in healthtech, fintech, proptech, mobility, and biopharma, with notable conviction in Latin American fintech.
  • The firm emphasizes active, multidisciplinary, operationally hands-on support for portfolio companies rather than passive capital.

Notable Investments

  • Nubank — Brazilian digital bank, one of the world's largest neobanks (Tarsadia was an early backer).
  • Creditas — Largest online secured-credit platform in Brazil.
  • Konfío — Digital banking/lending platform for SMBs in Mexico.
  • Bolttech — Insurance infrastructure ("insurtech") platform; participated in a Series A extension that reportedly reached ~US$210M.
  • AvantStay — Tech-enabled short-term / high-end vacation rental platform; Tarsadia co-led a $160M Series B.
  • Petal — Consumer credit card using cash-flow underwriting for thin-file borrowers.
  • Fathom — AI/ML platform automating medical coding and revenue-cycle management (invested 2019).
  • Erasca — Clinical-stage precision oncology company (RAS/MAPK pathway); later IPO'd on Nasdaq.
  • Amneal Pharmaceuticals — Generic and specialty pharmaceutical developer/manufacturer.
  • Kashiv Biosciences — Fully integrated biopharma developing biosimilars and specialty products.
  • Justo — Vertically integrated grocery e-commerce platform in Mexico City.
  • TrueMotion — Mobile telematics platform for auto insurers (acquired 2021).
  • Nvoicepay — Payment automation fintech (exited 2019).
  • Lereta — Outsourced mortgage/real-estate tax service provider (exited 2021).

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.